Delivery of DNA-based cancer vaccine with polyethylenimine

European Journal of Pharmaceutical Sciences

Volumn 40, Issue 2, 2010, Pages 75-83

  Ma, Yi Fan ^a   Yang, Ya Wun ^a  

^a NATIONAL TAIWAN UNIVERSITY   (Taiwan)

Author keywords

Cancer vaccine; DNA; Polyethylenimine

Indexed keywords

CANCER VACCINE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; POLYETHYLENEIMINE; SYNAPTOTAGMIN I;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN EXPRESSION; ANTIGEN SPECIFICITY; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER ADJUVANT THERAPY; CANCER IMMUNIZATION; CANCER INHIBITION; CANCER PREVENTION; CANCER SURVIVAL; CELL ACTIVATION; CONTROLLED STUDY; DNA IMMUNIZATION; DRUG CYTOTOXICITY; FEMALE; IMMUNOGENICITY; IMMUNOHISTOCHEMISTRY; IN VIVO STUDY; LYMPHOCYTIC INFILTRATION; MAJOR HISTOCOMPATIBILITY COMPLEX; MOUSE; NONHUMAN; NONVIRAL GENE DELIVERY SYSTEM; PRIORITY JOURNAL; SURVIVAL RATE; THYMOMA; TUMOR CELL DESTRUCTION; TUMOR IMMUNITY; WESTERN BLOTTING;

ADJUVANTS, IMMUNOLOGIC; ANIMALS; ANTIGENS, NEOPLASM; APOPTOSIS; CANCER VACCINES; CELL LINE; FEMALE; IMMUNOHISTOCHEMISTRY; MICE; MICE, INBRED C57BL; NEOPLASMS, EXPERIMENTAL; OVALBUMIN; POLYETHYLENEIMINE; T-LYMPHOCYTES, CYTOTOXIC; THYMOMA; VACCINES, DNA;

EID: 77952240642     PISSN: 09280987     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejps.2010.02.009     Document Type: Article

References (33)

1. Aggarwal B.B. Nuclear factor-kappaB: the enemy within. Cancer Cell 2004, 6:203-208.
2. Ai H., Jones S.A., de Villiers M.M., Lvov Y.M. Nano-encapsulation of furosemide microcrystals for controlled drug release. J. Control Release 2003, 86:59-68.
3. Bijker M.S., van den Eeden S.J., Franken K.L., Melief C.J., Offringa R., van der Burg S.H. CD8+ CTL priming by exact peptide epitopes in incomplete Freund's adjuvant induces a vanishing CTL response, whereas long peptides induce sustained CTL reactivity. J. Immunol. 2007, 179:5033-5040.
4. Breuzard G., Tertil M., Goncalves C., Cheradame H., Geguan P., Pichon C., Midoux P. Nuclear delivery of NFkappaB-assisted DNA/polymer complexes: plasmid DNA quantitation by confocal laser scanning microscopy and evidence of nuclear polyplexes by FRET imaging. Nucleic Acids Res. 2008, 36. e71-.
5. Coles R.M., Mueller S.N., Heath W.R., Carbone F.R., Brooks A.G. Progression of armed CTL from draining lymph node to spleen shortly after localized infection with herpes simplex virus 1. J. Immunol. 2002, 168:834-838.
6. Diebold S.S., Lehrmann H., Kursa M., Wagner E., Cotten M., Zenke M. Efficient gene delivery into human dendritic cells by adenovirus polyethylenimine and mannose polyethylenimine transfection. Hum. Gene Ther. 1999, 10:775-786.
7. Galea-Lauri J., Wells J.W., Darling D., Harrison P., Farzaneh F. Strategies for antigen choice and priming of dendritic cells influence the polarization and efficacy of antitumor T-cell responses in dendritic cell-based cancer vaccination. Cancer Immunol. Immunother. 2004, 53:963-977.
8. Garzon M.R., et al. Induction of gp120-specific protective immune responses by genetic vaccination with linear polyethylenimine-plasmid complex. Vaccine 2005, 23:1384-1392.
9. Godbey W.T., Wu K.K., Mikos A.G. Tracking the intracellular path of poly(ethylenimine)/DNA complexes for gene delivery. Proc. Natl. Acad. Sci. U.S.A. 1999, 96:5177-5181.
10. Godbey W.T., Wu K.K., Mikos A.G. Poly(ethylenimine)-mediated gene delivery affects endothelial cell function and viability. Biomaterials 2001, 22:471-480.
11. Hernandez J., Aung S., Redmond W.L., Sherman L.A. Phenotypic and functional analysis of CD8(+) T cells undergoing peripheral deletion in response to cross-presentation of self-antigen. J. Exp. Med. 2001, 194:707-717.
12. Inaba K., Inaba M., Romani N., Aya H., Deguchi M., Ikehara S., Muramatsu S., Steinman R.M. Generation of large numbers of dendritic cells from mouse bone marrow cultures supplemented with granulocyte/macrophage colony-stimulating factor. J. Exp. Med. 1992, 176:1693-1702.
13. Karttunen J., Sanderson S., Shastri N. Detection of rare antigen-presenting cells by the lacZ T-cell activation assay suggests an expression cloning strategy for T-cell antigens. Proc. Natl. Acad. Sci. U.S.A. 1992, 89:6020-6024.
14. Karttunen J., Shastri N. Measurement of ligand-induced activation in single viable T cells using the lacZ reporter gene. Proc. Natl. Acad. Sci. U.S.A. 1991, 88:3972-3976.
15. Kasturi S.P., Sachaphibulkij K., Roy K. Covalent conjugation of polyethyleneimine on biodegradable microparticles for delivery of plasmid DNA vaccines. Biomaterials 2005, 26:6375-6385.
16. Kichler A., Leborgne C., Coeytaux E., Danos O. Polyethylenimine-mediated gene delivery: a mechanistic study. J. Gene Med. 2001, 3:135-144.
17. Kircheis R., Wightman L., Wagner E. Design and gene delivery activity of modified polyethylenimines. Adv. Drug Deliv. Rev. 2001, 53:341-358.
18. Kleindienst P., Wiethe C., Lutz M.B., Brocker T. Simultaneous induction of CD4 T cell tolerance and CD8 T cell immunity by semimature dendritic cells. J. Immunol. 2005, 174:3941-3947.
19. Mesika A., Grigoreva I., Zohar M., Reich Z. A regulated, NFkappaB-assisted import of plasmid DNA into mammalian cell nuclei. Mol. Ther. 2001, 3:653-657.
20. Mesika A., Kiss V., Brumfeld V., Ghosh G., Reich Z. Enhanced intracellular mobility and nuclear accumulation of DNA plasmids associated with a karyophilic protein. Hum. Gene Ther. 2005, 16:200-208.
21. Moore M.W., Carbone F.R., Bevan M.J. Introduction of soluble protein into the class I pathway of antigen processing and presentation. Cell 1988, 54:777-785.
22. Moron G., Dadaglio G., Leclerc C. New tools for antigen delivery to the MHC class I pathway. Trends Immunol. 2004, 25:92-97.
23. Negulescu P.A., Shastri N., Cahalan M.D. Intracellular calcium dependence of gene expression in single T lymphocytes. Proc. Natl. Acad. Sci. U.S.A. 1994, 91:2873-2877.
24. O'Hagan D.T., Singh M., Ulmer J.B. Microparticle-based technologies for vaccines. Methods 2006, 40:10-19.
25. Orson F.M., Kinsey B.M., Densmore C.L., Nguyen T., Wu Y., Mbawuike I.N., Wyde P.R. Protection against influenza infection by cytokine-enhanced aerosol genetic immunization. J. Gene Med. 2006, 8:488-497.
26. Oster C.G., Kim N., Grode L., Barbu-Tudoran L., Schaper A.K., Kaufmann S.H., Kissel T. Cationic microparticles consisting of poly(lactide-co-glycolide) and polyethylenimine as carriers systems for parental DNA vaccination. J. Control Release 2005, 104:359-377.
27. Rice J., Ottensmeier C.H., Stevenson F.K. DNA vaccines: precision tools for activating effective immunity against cancer. Nat. Rev. Cancer 2008, 8:108-120.
28. Sanderson S., Shastri N. LacZ inducible, antigen/MHC-specific T cell hybrids. Int. Immunol. 1994, 6:369-376.
29. Shastri N., Gonzalez F. Endogenous generation and presentation of the ovalbumin peptide/Kb complex to T cells. J. Immunol. 1993, 150:2724-2736.
30. Vuorimaa E., Urtti A., Seppanen R., Lemmetyinen H., Yliperttula M. Time-resolved fluorescence spectroscopy reveals functional differences of cationic polymer-DNA complexes. J. Am. Chem. Soc. 2008, 130:11695-11700.
31. Yockman J.W., Kim W.J., Chang C.W., Kim S.W. Non-viral delivery of interleukin-2 and soluble Flk-1 inhibits metastatic and primary tumor growth in renal cell carcinoma. Gene Ther. 2007, 14:1399-1405.
32. Zhou F., Rouse B.T., Huang L. Prolonged survival of thymoma-bearing mice after vaccination with a soluble protein antigen entrapped in liposomes: a model study. Cancer Res. 1992, 52:6287-6291.
33. Zhou Y., Bosch M.L., Salgaller M.L. Current methods for loading dendritic cells with tumor antigen for the induction of antitumor immunity. J. Immunother. 2002, 25:289-303.